UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 184

Sortiert nach

Dual Chromatin and Cytoskeletal Remodeling by SETD2

Cell, 2016-08, Vol.166 (4), p.950-962

2016

Volltextzugriff (PDF)

Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time

Scientific reports, 2023-06, Vol.13 (1), p.10544-10544, Article 10544

2023

Volltextzugriff (PDF)

A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma

European urology, 2021-12, Vol.80 (6), p.712-723

2021

Volltextzugriff (PDF)

Behavior of blood plasma glycan features in bladder cancer

PloS one, 2018-07, Vol.13 (7), p.e0201208-e0201208

2018

Volltextzugriff (PDF)

Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia

eLife, 2017-12, Vol.6

2017

Volltextzugriff (PDF)

MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers

Nature communications, 2022-04, Vol.13 (1), p.1797-1797, Article 1797

2022

Volltextzugriff (PDF)

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness

European urology, 2017-06, Vol.71 (6), p.979-985

2017

Volltextzugriff (PDF)

DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas

Clinical cancer research, 2016-12, Vol.22 (24), p.6236-6246

2016

Volltextzugriff (PDF)

Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach

Cancers, 2023-03, Vol.15 (6), p.1673

2023

Volltextzugriff (PDF)

Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma

Cancer research (Chicago, Ill.), 2015-01, Vol.75 (2), p.316-329

2015

Volltextzugriff (PDF)

SETD2 loss in renal epithelial cells drives epithelial‐to‐mesenchymal transition in a TGF‐β‐independent manner

Molecular oncology, 2024-01, Vol.18 (1), p.44-61

2024

Volltextzugriff (PDF)

Factors Associated with Survival following Radium-223 Treatment for Metastatic Castration- Resistant Prostate Cancer

Clinical genitourinary cancer, 2017-12, Vol.15 (6), p.e969-e975

2017

Volltextzugriff (PDF)

The Impact of Pazopanib on the Cardiovascular System

Journal of Cardiovascular Pharmacology and Therapeutics, 2018-09, Vol.23 (5), p.387-398

2018

Volltextzugriff (PDF)

Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors

Current oncology (Toronto), 2021-12, Vol.28 (6), p.5466-5479

2021

Volltextzugriff (PDF)

Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines

Oncotarget, 2015-07, Vol.6 (21), p.18418-18428

2015

Volltextzugriff (PDF)

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma

Cancer medicine (Malden, MA), 2019-09, Vol.8 (12), p.5760-5768

2019

Volltextzugriff (PDF)

Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome

Clinical epigenetics, 2023-04, Vol.15 (1), p.71-71, Article 71

2023

Volltextzugriff (PDF)

Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy

Human molecular genetics, 2005-06, Vol.14 (11), p.1539-1547

2005

Volltextzugriff (PDF)

Lgr5-positive endothelial progenitor cells occupy a tumor and injury prone niche in the kidney vasa recta

Stem cell research, 2020-07, Vol.46, p.101849-101849, Article 101849

2020

Volltextzugriff (PDF)

Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis

Journal of translational medicine, 2016-07, Vol.14 (1), p.198-198, Article 198

2016

Volltextzugriff (PDF)

Loss of PBRM1 and BAP1 expression is less common in non–clear cell renal cell carcinoma than in clear cell renal cell carcinoma

Urologic oncology, 2015-01, Vol.33 (1), p.23.e9-23.e14

2015

Volltextzugriff (PDF)

Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma

Cancer medicine (Malden, MA), 2020-02, Vol.9 (3), p.1152-1160

2020

Volltextzugriff (PDF)

8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness

BMC urology, 2020-10, Vol.20 (1), p.1-173, Article 173

2020

Volltextzugriff (PDF)

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona

PloS one, 2015-07, Vol.10 (7), p.e0132831

2015

Volltextzugriff (PDF)

1 – 25 von 184

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Dual Chromatin and Cytoskeletal Remodeling by SETD2

Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time

A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma

Behavior of blood plasma glycan features in bladder cancer

Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia

MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness

DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas

Performing Automatic Identification and Staging of Urothelial Carcinoma in Bladder Cancer Patients Using a Hybrid Deep-Machine Learning Approach

Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma

SETD2 loss in renal epithelial cells drives epithelial‐to‐mesenchymal transition in a TGF‐β‐independent manner

Factors Associated with Survival following Radium-223 Treatment for Metastatic Castration- Resistant Prostate Cancer

The Impact of Pazopanib on the Cardiovascular System

Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors

Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines

In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma

Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome

Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy

Lgr5-positive endothelial progenitor cells occupy a tumor and injury prone niche in the kidney vasa recta

Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis

Loss of PBRM1 and BAP1 expression is less common in non–clear cell renal cell carcinoma than in clear cell renal cell carcinoma

Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma

8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona

Aktive Filter

Suchergebnisse filtern